These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2589388)

  • 1. Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers.
    Sörgel F; Naber KG; Jaehde U; Reiter A; Seelmann R; Sigl G
    Am J Med; 1989 Nov; 87(5A):62S-65S. PubMed ID: 2589388
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F
    Chemioterapia; 1988 Dec; 7(6):382-6. PubMed ID: 3219749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of flecainide absorption by activated charcoal.
    Nitsch J; Köhler U; Neyses L; Lüderitz B
    Am J Cardiol; 1987 Sep; 60(8):753. PubMed ID: 3116835
    [No Abstract]   [Full Text] [Related]  

  • 4. Activated charcoal and the absorption of ferrous sulfate in rats.
    Gades NM; Chyka PA; Butler AY; Virgous CK; Mandrell TD
    Vet Hum Toxicol; 2003 Aug; 45(4):183-7. PubMed ID: 12882486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective gastrointestinal clearance of disopyramide in rabbits treated with activated charcoal.
    Huang JD
    J Pharm Sci; 1988 Nov; 77(11):959-62. PubMed ID: 3225758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of acute poisoning with activated charcoal.
    Corby DG; Decker WJ
    Pediatrics; 1974 Sep; 54(3):324-9. PubMed ID: 4606780
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastrointestinal clearance of drugs with activated charcoal.
    Levy G
    N Engl J Med; 1982 Sep; 307(11):676-8. PubMed ID: 7110218
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of activated charcoal on diethylcarbamazine absorption in humans.
    Orisakwe OE; Ilondu ND; Afonne OJ; Ofoefule SI; Orish CN; Agbasi PU
    Am J Ther; 2001; 8(1):7-9. PubMed ID: 11304652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of charcoal-broiled beef on phenacetin metabolism in man.
    Pantuck EJ; Hsiao KC; Conney AH; Garland WA; Kappas A; Anderson KE; Alvares AP
    Science; 1976 Dec; 194(4269):1055-7. PubMed ID: 982059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol absorption in different regions of the rat gastrointestinal tract in situ: implications for sustained release formulations.
    Taylor DC; Grundy R
    J Pharm Pharmacol; 1980 Jul; 32(7):499-500. PubMed ID: 6105188
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded role of charcoal therapy in the poisoned and overdosed patient.
    Park GD; Spector R; Goldberg MJ; Johnson GF
    Arch Intern Med; 1986 May; 146(5):969-73. PubMed ID: 3516107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of activated charcoal on the absorption of amiodarone.
    Kivistö KT; Neuvonen PJ
    Hum Exp Toxicol; 1991 Sep; 10(5):327-9. PubMed ID: 1683545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate.
    Wong PY; Zhu M; Li RC
    J Chemother; 2000 Aug; 12(4):286-93. PubMed ID: 10949977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of activated charcoal on isoniazid absorption in rabbits.
    Ofoefule SI; Onuoha LC; Okonta MJ; Udeogaranya PO; Orisakwe OE
    Boll Chim Farm; 2001; 140(3):183-6. PubMed ID: 11486611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental observations on flufenamic, mefenamic and meclofenamic acids. 3. Metabolic disposition.
    Glazko AJ
    Ann Phys Med; 1966; Suppl():23-36. PubMed ID: 4979052
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule.
    Harder S; Fuhr U; Beermann D; Staib AH
    Br J Clin Pharmacol; 1990 Jul; 30(1):35-9. PubMed ID: 2390430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.